IPN Ipsen SA

IPSEN : Déclaration des transactions sur actions propres réalisées du 28 juin au 02 Juillet 2021

Regulatory News :

Présentation agrégée par jour et par marché

Nom de l'émetteur Code identifiant de l'émetteur

(code LEI)
Jour de la

transaction
Code identifiant de

l'instrument financier

Volume total journalier

(en nombre de titres)

Prix pondéré

moyen journalier

d'acquisition

Code

identifiant

marché
IPSEN 549300M6SGDPB4Z94P11 6/28/2021 FR0010259150

18690

85,66

XPAR
IPSEN 549300M6SGDPB4Z94P11 6/28/2021 FR0010259150

48

85,3

CEUX
IPSEN 549300M6SGDPB4Z94P11 6/28/2021 FR0010259150

16

85,3

AQUIS
IPSEN 549300M6SGDPB4Z94P11 6/29/2021 FR0010259150

283

86,4842

XPAR
IPSEN 549300M6SGDPB4Z94P11 6/30/2021 FR0010259150

12536

87,0683

XPAR
IPSEN 549300M6SGDPB4Z94P11 7/1/2021 FR0010259150

5263

87,8576

XPAR
IPSEN 549300M6SGDPB4Z94P11 7/2/2021 FR0010259150

5268

87,9085

XPAR
IPSEN 549300M6SGDPB4Z94P11 7/2/2021 FR0010259150

1114

87,8458

CEUX
IPSEN 549300M6SGDPB4Z94P11 7/2/2021 FR0010259150

718

87,885

TQEX
TOTAL

43 936

86,6912

 

FR
06/07/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Ipsen SA

Christophe-Raphaël Ganet
  • Christophe-Raphaël Ganet
Christophe-Raphaël Ganet
  • Christophe-Raphaël Ganet
 PRESS RELEASE

Ipsen announces the availability of its 2025 Universal Registration Do...

Ipsen announces the availability of its 2025 Universal Registration Document Ipsen announces the availability of its 2025 Universal Registration Document PARIS, FRANCE, 1 APRIL 2026 - Ipsen (Euronext: IPN; ADR: IPSEY) announced that its 2025 Universal Registration Document has been filed today with the French Autorité des Marchés Financiers (AMF) and registered under the number D.26-0202. The document is available on and . Copies will also be available at Ipsen’s headquarters – 70 rue Balard, 75015 Paris, France. The Universal Registration Document includes in particular: the Annual F...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch